Humalog Mix 50 100IU Kwikpen

About

Humalog Mix 50 100IU Kwikpen is a pre-mixed insulin formulation designed for individuals with diabetes requiring both rapid-acting and intermediate-acting insulin. It contains 50% insulin lispro (rapid-acting) and 50% insulin lispro protamine suspension (intermediate-acting). This combination provides quick glucose lowering after meals due to the rapid-acting component, while the intermediate-acting component offers sustained glucose control between meals and overnight. This convenient formulation simplifies insulin therapy by reducing the number of injections needed compared to separate rapid and intermediate insulin administrations. It helps to achieve better overall glycemic control by addressing both postprandial hyperglycemia and basal insulin needs, contributing to improved HbA1c levels and a more flexible lifestyle for patients managing type 1 or type 2 diabetes.

Uses

• Management of Type 1 diabetes mellitus.
• Management of Type 2 diabetes mellitus.
• Achieving comprehensive glycemic control.
• Addressing both basal and mealtime insulin needs.

Directions For Use

Administer subcutaneously 0-15 minutes before or immediately after a meal, as directed by your doctor. Rotate injection sites.

Benefits

• Convenient pre-mixed insulin formulation.
• Provides rapid onset of action for meals.
• Offers sustained glucose control between meals.
• Reduces the total number of daily injections.
• Allows for flexible meal timing.
• Improves post-meal glucose excursions.

Side Effects

• Hypoglycemia (low blood sugar).
• Injection site reactions (redness, pain, swelling).
• Weight gain.
• Peripheral edema (swelling of extremities).
• Lipodystrophy (skin changes at injection site).
• Allergic reactions (rash, itching).
• Blurred vision (temporary).
• Flu-like symptoms.
• Headache.
• Nausea.
• Diarrhea.
• Fatigue.

Safety Measures

• Alcohol - Alcohol can increase the risk of hypoglycemia; consume in moderation or avoid.
• Pregnancy - Consult doctor; insulin needs may change. Generally considered safe, but close monitoring is essential.
• Breastfeeding - Consult doctor; insulin is generally safe, but monitor infant for hypoglycemia.
• Liver - Use with caution; liver impairment may alter insulin metabolism, requiring dose adjustment.
• Kidney - Use with caution; renal impairment can affect insulin clearance, necessitating dose adjustment.
• Lung - No specific direct contraindication, but monitor for fluid retention in patients with severe heart failure.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.